Workflow
Gray Media Names Eric Walters as General Manager of KNOE and KAQY in Monroe, Louisiana
Globenewswire· 2025-07-31 18:30
ATLANTA, July 31, 2025 (GLOBE NEWSWIRE) -- Gray Media has named Eric Walters as the next General Manager of KNOE and KAQY-LD, Gray’s CBS and ABC affiliates in Monroe, Louisiana, effective September 1, 2025. Eric is currently General Manager of KMVT (CBS) and KSVT-LD (FOX) in Twin Falls, Idaho. During his tenure, he worked with station leaders to grow ratings in all newscasts and to significantly increase digital content across all platforms. Eric previously served as the News Director of Gray’s WDBJ (CBS ...
Campine’s agile navigation through the trade war effects
Globenewswire· 2025-07-31 18:30
Beerse, Belgium – July 31, 2025 – 20:30 CET Campine NV, metals recycling and specialty chemicals company from Beerse, Belgium and listed on Euronext Brussels, navigates in an agile way through the different effects of trade wars. Following the U.S. administration’s announcement on April 2nd, 2025, of new import tariffs for European products, Campine received official confirmation that its antimony trioxide (ATO) is exempt from these duties. This contrasts sharply with the 15% tariffs now applied to most oth ...
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor “What This Means” Segment
Globenewswire· 2025-07-31 17:50
Company Overview - GRI Bio, Inc. is a biotechnology company focused on developing Natural Killer T (NKT) cell modulators for treating inflammatory, fibrotic, and autoimmune diseases [3] - The company is in the clinical stage and aims to fundamentally change treatment approaches for these diseases [3] Recent Developments - GRI Bio participated in a Virtual Investor segment where CEO Marc Hertz discussed interim biomarker data from a Phase 2a study in Idiopathic Pulmonary Fibrosis (IPF) [2] - The interim data was collected over a 6-week period, indicating progress in the ongoing study [2] Product Pipeline - GRI Bio's lead program, GRI-0621, is an inhibitor of iNKT cell activity, being developed as an oral therapeutic for IPF, which has significant unmet medical needs [3] - The company is also developing a pipeline of novel type 2 diverse NKT (dNKT) agonists aimed at treating systemic lupus erythematosus [3] - GRI Bio possesses a library of over 500 proprietary compounds, which supports the expansion of its product pipeline [3]
LLYC grows recurring EBITDA by 15% in H1, reaching €7.9 million
Globenewswire· 2025-07-31 17:38
Total income rose nearly 19% to €64.8 million, while operating income grew by 6.1% to €45.8 millionThe Marketing and Corporate Affairs firm updates its financial guidance for 2025LLYC remains focused on growth and protecting profitability amid global uncertainty and delayed investments MADRID, July 31, 2025 (GLOBE NEWSWIRE) -- LLYC (BME:LLYC) closed the first half of 2025 with a 15% increase in recurring EBITDA, reaching €7.9 million. According to the preliminary results — pending final audit — the Marketin ...
Viridien: 2025 Interim Financial Report available
Globenewswire· 2025-07-31 17:17
Viridien Société Anonyme with a share capital of €7,180,449Registered office: 27 avenue Carnot, 91300 MassyNo.: 969 202 241 – RCS Evry 2025 Interim Financial Report available Paris, France – July 31, 2025 Viridien announced that its interim financial report as at June 30, 2025 was filed today with the Autorité des Marchés Financiers (AMF). This document is available on the Company’s website: https://www.viridiengroup.com/ under the Investors section (both in “Regulated information” and “Results and Publicat ...
RCI Banque: ‘’2025 First Half Business Report is now available’’
Globenewswire· 2025-07-31 16:30
July 31st, 2025 RCI Banque: ‘’2025 First Half Business Report is now available’’ The RCI Banque group ‘’2025 First Half Business Report’’ is now available on the Mobilize Financial Services website www.mobilize-fs.com Attachment Press Release - Report activity 2024 ...
Availability of 2025 Half-Year Financial Report
Globenewswire· 2025-07-31 16:30
Press Release Paris – July 31, 2025 – EUROAPI posted today its 2025 condensed Half-Year Consolidated Financial Statements for the six months ended June 30, 2025. This document is available for consultation and downloading on EUROAPI’s website: https://www.euroapi.com/en/investors/regulatory-information/financial-reports. This report includes notably the 2025 half-year management report, the consolidated financial statements on 30 June 2025, and the Statutory Auditors’ review report on the half-yearly fi ...
Press release: Online availability of Sanofi’s half-year financial report for 2025
Globenewswire· 2025-07-31 16:20
Online availability of Sanofi’s half-year financial report for 2025 Paris, July 31, 2025. Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K. This document may be found on the company’s corporate website: www.sanofi.com and downloaded from the “Investors” page, under the heading “Re ...
SMCP - Notification of availability of SMCP 2025 Interim financial report
Globenewswire· 2025-07-31 16:14
Paris, July 31st, 2025 Notification of availability of SMCP 2025 interim financial report SMCP announces that its interim financial report for the six-month period ended June 30, 2025, has been made available to the public and filed with the Autorité des marchés financiers today. The interim financial report is available on SMCP’s website: www.smcp.com(Part: Finance / Section: Publications & events / Financial reports) ABOUT SMCP SMCP is a global leader in the accessible luxury market with four unique Pari ...
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
Globenewswire· 2025-07-31 16:12
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2025, before market open on August 14, 2025. Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Thursday, August 14, 2 ...